Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5675779 | American Journal of Obstetrics and Gynecology | 2017 | 29 Pages |
Abstract
Type 1 or type 2 retinopathy of prematurity are adverse ocular outcomes linked with not only lower gestational age and birth weight at delivery but also with events in the intrauterine environment that trigger a preterm birth. The reduced incidence of type 1 or type 2 retinopathy of prematurity in the preterm premature rupture of the membranes group compared with other causes of preterm birth may be related to the perinatal therapies associated with preterm premature rupture of the membranes (such as corticosteroids, antibiotics, maternal-fetal surveillance), which may have an inhibitory effect on the development of retinopathy of prematurity. We suggest that the physiologic events that predispose infants to type 1 or type 2 retinopathy of prematurity begin before delivery.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Anne M. MB, BCH, BAO, MSPH, Brandie D. PhD, Jennifer K. MD, PhD, Tamara S. MS, Emily A. MD, Ashlee M. MPH, Naresh MD, Ronald S. MD, Alan G. MD,